IXI vs. SAR, AREC, AOR, IMM, OPTI, RLM, NSCI, BVX, FAB, and APTA
Should you be buying IXICO stock or one of its competitors? The main competitors of IXICO include Sareum (SAR), Arecor Therapeutics (AREC), AorTech International (AOR), ImmuPharma (IMM), OptiBiotix Health (OPTI), Realm Therapeutics (RLM), NetScientific (NSCI), BiVictriX Therapeutics (BVX), Fusion Antibodies (FAB), and Aptamer Group (APTA). These companies are all part of the "biotechnology" industry.
IXICO vs.
Sareum (LON:SAR) and IXICO (LON:IXI) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, media sentiment, risk, valuation, community ranking and earnings.
IXICO has higher revenue and earnings than Sareum. Sareum is trading at a lower price-to-earnings ratio than IXICO, indicating that it is currently the more affordable of the two stocks.
Sareum has a net margin of 0.00% compared to IXICO's net margin of -31.10%. IXICO's return on equity of -19.14% beat Sareum's return on equity.
Sareum has a beta of -1.08, suggesting that its share price is 208% less volatile than the S&P 500. Comparatively, IXICO has a beta of 0.86, suggesting that its share price is 14% less volatile than the S&P 500.
In the previous week, Sareum's average media sentiment score of 0.00 equaled IXICO'saverage media sentiment score.
56.0% of IXICO shares are held by institutional investors. 5.0% of Sareum shares are held by insiders. Comparatively, 30.3% of IXICO shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
IXICO received 62 more outperform votes than Sareum when rated by MarketBeat users. Likewise, 71.64% of users gave IXICO an outperform vote while only 66.13% of users gave Sareum an outperform vote.
Summary
IXICO beats Sareum on 11 of the 12 factors compared between the two stocks.
Get IXICO News Delivered to You Automatically
Sign up to receive the latest news and ratings for IXI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
This page (LON:IXI) was last updated on 2/22/2025 by MarketBeat.com Staff
